248 related articles for article (PubMed ID: 25503969)
1. Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice.
Schully KL; Bell MG; Ward JM; Keane-Myers AM
PLoS One; 2014; 9(12):e115066. PubMed ID: 25503969
[TBL] [Abstract][Full Text] [Related]
2. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against
Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
[No Abstract] [Full Text] [Related]
4. Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs.
Zou N; Tsai S; Feng SH; Newsome T; Kim HY; Li B; Zhang S; Lo SC
Hybridoma (Larchmt); 2008 Aug; 27(4):231-40. PubMed ID: 18707541
[TBL] [Abstract][Full Text] [Related]
5. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.
Memišević V; Kumar K; Zavaljevski N; DeShazer D; Wallqvist A; Reifman J
BMC Bioinformatics; 2016 Sep; 17():387. PubMed ID: 27650316
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
[TBL] [Abstract][Full Text] [Related]
7. Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.
Goodyear A; Kellihan L; Bielefeldt-Ohmann H; Troyer R; Propst K; Dow S
Infect Immun; 2009 Apr; 77(4):1579-88. PubMed ID: 19179415
[TBL] [Abstract][Full Text] [Related]
8. Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.
Balder R; Lipski S; Lazarus JJ; Grose W; Wooten RM; Hogan RJ; Woods DE; Lafontaine ER
BMC Microbiol; 2010 Sep; 10():250. PubMed ID: 20920184
[TBL] [Abstract][Full Text] [Related]
9. Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei.
Feng SH; Tsai S; Rodriguez J; Newsome T; Emanuel P; Lo SC
Hybridoma (Larchmt); 2006 Aug; 25(4):193-201. PubMed ID: 16934015
[TBL] [Abstract][Full Text] [Related]
10. Development of Burkholderia mallei and pseudomallei vaccines.
Silva EB; Dow SW
Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
[TBL] [Abstract][Full Text] [Related]
11. An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency.
Saikh KU; Dankmeyer JL; Zeng X; Ulrich RG; Amemiya K
Immun Inflamm Dis; 2019 Mar; 7(1):7-21. PubMed ID: 30569531
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei.
Alam S; Amemiya K; Bernhards RC; Ulrich RG; Waag DM; Saikh KU
Microb Pathog; 2015 Jan; 78():20-8. PubMed ID: 25450887
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.
Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A
Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.
Barnes KB; Steward J; Thwaite JE; Lever MS; Davies CH; Armstrong SJ; Laws TR; Roughley N; Harding SV; Atkins TP; Simpson AJ; Atkins HS
Int J Antimicrob Agents; 2013 Jun; 41(6):552-7. PubMed ID: 23517714
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species.
Chiang CY; Ulrich RL; Ulrich MP; Eaton B; Ojeda JF; Lane DJ; Kota KP; Kenny TA; Ladner JT; Dickson SP; Kuehl K; Raychaudhuri R; Sun M; Bavari S; Wolcott MJ; Covell D; Panchal RG
BMC Microbiol; 2015 Nov; 15():259. PubMed ID: 26545875
[TBL] [Abstract][Full Text] [Related]
18. Burkholderia mallei and Burkholderia pseudomallei stimulate differential inflammatory responses from human alveolar type II cells (ATII) and macrophages.
Lu R; Popov V; Patel J; Eaves-Pyles T
Front Cell Infect Microbiol; 2012; 2():165. PubMed ID: 23293773
[TBL] [Abstract][Full Text] [Related]
19. Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker.
Zajdowicz SL; Jones-Carson J; Vazquez-Torres A; Jobling MG; Gill RE; Holmes RK
PLoS One; 2011; 6(6):e21523. PubMed ID: 21720554
[TBL] [Abstract][Full Text] [Related]
20. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
Galyov EE; Brett PJ; DeShazer D
Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
